Eric ANGEVIN
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Immunology 45
- Immunotherapy and Immune Responses 30
- Immune Cell Function and Interaction 19
- T-cell and B-cell Immunology 13
- Oncology 50
- Cancer Immunotherapy and Biomarkers 27
- CAR-T cell therapy research 13
- Co-authors
- laurence ZITVOGEL (21 shared papers)Thomas Tursz (10 shared papers)Caroline Flament (11 shared papers)Sebastián Amigorena (5 shared papers)Graça Raposo (5 shared papers)Bernard J. Escudier (28 shared papers)Fabrice André (11 shared papers)Joseph Wolfers (3 shared papers)
- Journals
- Annals of Oncology (25 papers)European Journal of Cancer (11 papers)International Journal of Cancer (10 papers)Clinical Cancer Research (9 papers)The Journal of Immunology (6 papers)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Eric ANGEVIN
125 papers receiving 10.7k citations
Eric ANGEVIN's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 2.5k
- Immunology 3.7k
- Oncology 3.3k
- Molecular Biology 5.2k
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Eric ANGEVIN
This map shows the geographic impact of Eric ANGEVIN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric ANGEVIN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric ANGEVIN more than expected).
Fields of papers citing papers by Eric ANGEVIN
This network shows the impact of papers produced by Eric ANGEVIN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric ANGEVIN. The network helps show where Eric ANGEVIN may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric ANGEVIN, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune-related adverse events with immune checkpoint blockade: a comprehensive review Hit paper breakdown → | 2016 | 1785 |
| 2 | Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming Hit paper breakdown → | 2001 | 1411 |
| 3 | Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial Hit paper breakdown → | 2005 | 1122 |
| 4 | Malignant effusions and immunogenic tumour-derived exosomes Hit paper breakdown → | 2002 | 839 |
| 5 | High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial Hit paper breakdown → | 2017 | 597 |
| 6 | 2004 | 442 | |
| 7 | 2004 | 243 | |
| 8 | 2004 | 232 | |
| 9 | 2002 | 188 | |
| 10 | 2014 | 176 | |
| 11 | 2017 | 170 | |
| 12 | 2003 | 148 | |
| 13 | Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. | 2001 | 138 |
| 14 | 2019 | 136 | |
| 15 | 1993 | 124 | |
| 16 | 2018 | 122 | |
| 17 | 2004 | 122 | |
| 18 | 2007 | 119 | |
| 19 | 2018 | 117 | |
| 20 | 2013 | 111 |
About Eric ANGEVIN
Eric ANGEVIN is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 128 papers that have together received 10.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (30 papers), Cancer Immunotherapy and Biomarkers (27 papers), Immune Cell Function and Interaction (19 papers), CAR-T cell therapy research (13 papers), T-cell and B-cell Immunology (13 papers), Extracellular vesicles in disease (12 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and RNA Interference and Gene Delivery (10 papers). The work is most often cited by research in Cancer Research (2.5k citations), Immunology (3.7k citations), Oncology (3.3k citations), Molecular Biology (5.2k citations) and Pulmonary and Respiratory Medicine (1.2k citations). Eric ANGEVIN has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include laurence ZITVOGEL, Thomas Tursz, Caroline Flament, Sebastián Amigorena, Graça Raposo, Bernard J. Escudier, Fabrice André, Joseph Wolfers, Anne Lozier and Clotilde Théry. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, International Journal of Cancer, Clinical Cancer Research and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.